ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
twitter youtube facebook linkedin iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Global Initiatives

European Perspective on Molecular Testing

on: May 31, 2017In: Global Initiatives
European Perspective on Molecular Testing

Posted: June 2017 By Νiki Karachaliou, MD, PhD The identification of oncogenic driver alterations in non-small cell lung cancer (NSCLC), such as EGFR mutations and ALK rearrangements, each of which […] Read more


IASLC International Mentorship Program Boosts Early Careers, Fosters International Collaboration

on: April 01, 2017In: Global Initiatives
IASLC International Mentorship Program Boosts Early Careers, Fosters International Collaboration

Posted: April 2017 By Keightley Amen, BA, ELS To help ensure that high-quality thoracic oncology care is available throughout the world and well into the future, the IASLC offers an […] Read more

Innovations in the 8th Edition of the TNM Classification of Lung Cancer Enhance Prognostic Capabilities

on: April 01, 2017In: Global Initiatives
Innovations in the 8th Edition of the TNM Classification of Lung Cancer Enhance Prognostic Capabilities

Posted: April 2017 By Cynthia L. Kryder, MS, CCC-Sp, with Ramón Rami-Porta, MD Clinicians around the world began implementing the 8th edition of the tumor, node, and metastasis (TNM) classification […] Read more

Lung Cancer in Never-Smokers: An Epidemiologic Perspective

Daniel S.W. Tan, MD, PhD
+more
on: February 01, 2017In: Global Initiatives
Lung Cancer in Never-Smokers: An Epidemiologic Perspective

Posted: February 2017 By Chee-Keong Toh, MD, and Daniel SW Tan, MD The recent decade has seen much interest in lung cancer in never-smokers (LCNS), in most part attributed to […] Read more

Lung Cancer in Women: Different or Not?

on: November 01, 2016In: Global Initiatives
Lung Cancer in Women: Different or Not?

By Julien Mazières, MD, PhD, and Julie Milia, PhD Once considered a “man’s disease,” lung cancer no longer discriminates. During the last decade, lung cancer in women has become the […] Read more

Epidemiology of Lung Cancer in Developing Countries

on: November 01, 2016In: Global Initiatives
Epidemiology of Lung Cancer in Developing Countries

By Jyoti Malhotra, MD, MPH and Paolo Boffetta, MD, MPH Lung cancer is the most frequent malignant neoplasm in most countries worldwide, and the main cause of cancer death in […] Read more

New Findings in Malignant Pleural Mesothelioma (MPM)

on: November 01, 2016In: Global Initiatives
New Findings in Malignant Pleural Mesothelioma (MPM)

Posted: November 1, 2016 How one investigator’s passion and devotion to science led to discovery of the “ghost gene” in MPM Q&A with Michele Carbone, MD Q: Many laboratories are […] Read more

Today’s Age of Drug Development Q & A with Kapil Dhingra, MD

on: September 01, 2016In: Global Initiatives
Today’s Age of Drug Development Q & A with Kapil Dhingra, MD

By Cynthia L. Kryder, MS IASLC Lung Cancer News recently spoke with Kapil Dhingra, MD, of KAPital Consulting LLC in Sparta, New Jersey, about oncologic drug development and the challenges […] Read more

Next-Generation Sequencing Across the World: Reports from France, Germany, and China

on: September 01, 2016In: Global Initiatives
Next-Generation Sequencing Across the World: Reports from France, Germany, and China

Next-generation sequencing (NGS) technology has revolutionized genomic and genetic research as it fulfills its potential to tailor the treatment of cancer patients in general and non-small cell lung cancer (NSCLC) […] Read more

Genetic Differences in Lung Cancers Arising in Smokers and Never-Smokers

on: September 01, 2016In: Global Initiatives
Genetic Differences in Lung Cancers Arising in Smokers and Never-Smokers

By Adi F. Gazdar, MD While all of the major histological forms of lung cancer are strongly associated with smoking, an important subset (about 20% worldwide, 10–15% in the US) […] Read more

1234
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2023 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy